Abbott’s Q2 showed resilience amid macro risks, with its dividend strength and fair valuation reinforcing long-term appeal.

With this in mind, three Motley Fool contributors have identified dividend stocks that they think retirees should absolutely ...

Investing.com -- UBS said in a note Friday that investors should scale back exposure to most cyclical stocks outside of a few ...

THW trades at a favorable discount to NAV and it's a potential accumulation opportunity, though risks remain if rates stay ...

An Abbott official said today that the company launched its latest-generation MitraClip and TriClip G5 systems.

Investors were disappointed with Abbott Laboratories' ( NYSE:ABT ) earnings, despite the strong profit numbers.

Wrapping up Q2 earnings, we look at the numbers and key takeaways for the medical devices & supplies - diversified stocks, ...

A former high-ranking official in the governor's administration is one of leaders poised to run "Y'all Street." ...

Reinsurance Group of America, Incorporated (NYSE: RGA), a leading global provider of life and health reinsurance, reported second quarter net income available to RGA shareholders of $180 million, or ...

New Doximity Study Shows Modest Physician Pay Growth Amid Deeper Workforce Strain, Reimbursement Pressures ...

Xtrackers SPXD ETF offers a balanced way to invest in S&P 500 without relying on tech giants like Nvidia. Its innovative ...

Tidepool announced that it began rolling out its new cloud-to-cloud integration with the Abbott (NYSE:ABT) FreeStyle Libre ...